Organisation paid for research Program year 2025 Source: CMS Open Payments

Aventiv Research, Inc.

Neither a doctor nor a teaching hospital

Research payments

$543,800

102 payments

Through program year 2025, Aventiv Research, Inc. is reported as receiving $543,800 in research payments, across 102 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$18,306	7
2024	Research	$19,490	5
2023	Research	$259,035	47
2022	Research	$169,412	27
2021	Research	$3,027	2
2020	Research	$52,542	9
2019	Research	$21,989	5

Breakdown

Who paid Research payments · program years 2019–2025

Bavarian Nordic A/S $311,466 60 payments
Chugai Pharmaceutical Co., Ltd. $142,247 24 payments
H. Lundbeck A S $40,134 3 payments
Chiesi USA, Inc. $18,276 3 payments
Genentech, Inc. $12,530 2 payments
Kowa Research Institute, Inc. $6,740 4 payments
Mitsubishi Tanabe Pharma Development America, Inc. $6,500 1 payment
VYNE Pharmaceuticals Inc. $5,908 5 payments

Studies the money was for Research payments · program years 2019–2025

A Randomized, Double-blind, Phase 3 Trial to Assess Clinical Efficacy, Safety and Reactogenicity of the Recombinant MVA-BN -RSVVaccine in Adults 60 Years of Age $157,054 34 payments
Nct05238025 $154,412 26 payments
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Biomarkers of Donq52 in Celiac Disease Patients $127,247 23 payments
Evaluate Efficacy & Safety of Eptinezumab Administered Intravenously in Subjects Experiencing Acute Attack of Migraine (RELIEF) $40,134 3 payments
Ccd-05993Aa3-01 $18,276 3 payments
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Biomarkers of Donq52 in Celiac Disease Patients $15,000 1 payment
Gazyva for the Treatment of MN $12,530 2 payments
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of MT-2990 in Women with Endometriosis Experiencing Endometrial Related Pain $6,500 1 payment
Mti-107 $5,908 5 payments
K-877-301 $3,175 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.